DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

JTEKT India FY26 net profit rises 2% to ₹769 crore

scanx.trade 1d ago·30 Aug 2026, 7:42 pm

JTEKT India has reported a net profit of ₹769 crore for the fiscal year ending March 2026, marking a modest 2% increase from the previous year. Despite the rise, the company's total income saw a decline of 4% to ₹5,523 crore. This financial performance suggests that while the company remains profitable, its core operations are facing headwinds that have impacted its top-line growth.

For investors, this mixed result indicates that JTEKT India is operating in a challenging environment, likely due to weak demand in key markets like automotive and industrial machinery. The drop in revenue, coupled with a slight rise in expenses, suggests that the company is struggling to maintain its pricing power. This could signal a need for operational efficiency or a strategic shift to navigate the current market conditions.

Investors should keep a close watch on the company's order book and its commentary on demand trends in the coming quarters. A recovery in the industrial cycle or cost-control measures could help stabilize the stock, while continued weakness in revenue may weigh on investor sentiment. Monitoring management's guidance will be crucial to understanding the company's path forward.